neuroClues closes €10M Series A to bring its eye-tracking Parkinson’s diagnostic to European and US neurologists

The Next Web
Read full post
NeuroClues secured €10 million in Series A funding to advance its eye-tracking technology for Parkinson's diagnosis, aiming to expand access among neurologists in Europe and the US. The funding will support clinical trials and regulatory approvals to bring this diagnostic tool to market.

More in Healthcare

Google DeepMind Releases AlphaGenome Atlas Mapping 9 Billion Human DNA

Forbes
Healthcare3 min read

Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his

TechCrunch

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources